Indications
Treatment of invasive candidiasis in adult patients, in combination with amphotericin B or a lipid formulation of amphotericin B.
Composition
- Active substance
- recombinant human monoclonal antibody to hsp
- International name (INN)
- efungumab
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Mycograb
- Active substance
- recombinant human monoclonal antibody to hsp
- ATC code
- J02
- Therapeutic area
- Candidiasis
- Marketing authorisation holder
- NeuTec Pharma plc